Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab in pediatric familial hypercholesterolemia (HAUSER-OLE)
NCT02624869Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2016
- Primary completion
- Jun 2021
- Modality
- Monoclonal Antibodies
- Countries
- 23
01
Overview
A Phase 3 trial of evolocumab in heterozygous familial hypercholesterolemia (HeFH), homozygous familial hypercholesterolemia (HoFH), sponsored by Amgen. Started Sep 2016; status: completed.
02
Drugs
evolocumab
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT02624869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624869.